Jazz Pharmaceuticals plc | Business Contracts

License and Collaboration Agreement, dated October 18, 2022, between Jazz Pharmaceuticals Ireland Limited and Zymeworks BC Inc (Filed With SEC on December 5, 2022)

Amended and Restated Non-Employee Director Compensation Policy (approved April 28, 2022) (Filed With SEC on August 3, 2022)

Description of Share Capital (Filed With SEC on March 1, 2022)

Jazz Pharmaceuticals plc (Filed With SEC on March 1, 2022)

Amendment No. 1, dated as of May 6, 2021, to Amended and Restated License Agreement, dated as of October 14, 2020, between Pharma Mar, S.A. and Jazz Pharmaceuticals Ireland Limited (Filed With SEC on August 3, 2021)

Amendment No. 7, dated as of September 28, 2022, to Pharmacy Master Services Agreement, dated as of (Filed With SEC on November 9, 2022)

Amendment No. 6, dated as of August 24, 2022, to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Filed With SEC on November 9, 2022)

Amendment No. 1 Clinical and Commercial Manufacturing and Supply Agreement, dated as of January 18, 2018, by and between Jazz Pharmaceuticals Ireland Limited and Baxter Oncology... (Filed With SEC on November 9, 2022)

Clinical and Commercial Manufacturing and Supply Agreement, dated as of December 22, 2010, between Celator Pharmaceuticals, Inc. and Baxter Oncology GmbH (Filed With SEC on November 9, 2022)

Settlement Agreement, dated as of April 5, 2017, by and between Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited, and Roxane Laboratories, Inc., West-Ward... (Filed With SEC on November 9, 2022)

Amendment No. 5, dated as of June 24, 2022, to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Filed With SEC on August 3, 2022)

Amendment No. 4, dated as of April 18, 2022 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Filed With SEC on May 4, 2022)

Amendment No (Filed With SEC on March 1, 2022)

Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Form of Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2011... (Filed With SEC on November 9, 2021)

Form of U.S. Performance Restricted Stock Unit Award Grant Notice and Form of U.S. Performance Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and... (Filed With SEC on August 3, 2021)

First Supplemental Indenture, dated as of July 21 (Filed With SEC on August 3, 2021)

Amendment No. 1, dated as of July 4, 2021 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty... (Filed With SEC on August 3, 2021)

Amendment No. 2, dated as of July 19, 2021 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty... (Filed With SEC on August 3, 2021)

Service Agreement, dated as of May 5, 2021, by and between Chris Tovey and Jazz Pharmaceuticals UK Limited (Filed With SEC on August 3, 2021)

Participation Agreement, dated as of May 5, 2021, by and between Chris Tovey and Jazz Pharmaceuticals UK Limited (Filed With SEC on August 3, 2021)

Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Form of Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2011... (Filed With SEC on August 3, 2021)

Form of Non-U.S. Performance Restricted Stock Unit Award Grant Notice and Form of Non-U.S. Performance Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc... (Filed With SEC on August 3, 2021)

Form of U.S. Restricted Stock Unit Award Grant Notice and Form of U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2011 Equity... (Filed With SEC on August 3, 2021)

Form of Restricted Stock Unit Award Agreement under the GW Pharmaceuticals plc 2020 Long-Term Incentive Plan (Filed With SEC on August 3, 2021)

Form of Replacement Stock Option Award Agreement under the GW Pharmaceuticals plc 2020 Long-Term Incentive Plan (Filed With SEC on August 3, 2021)

Form of Replacement Restricted Stock Unit Award Agreement under the GW Pharmaceuticals plc 2020 Long-Term Incentive Plan (Filed With SEC on August 3, 2021)

Amended and Restated Non-Employee Director Compensation Policy (approved (Filed With SEC on August 3, 2021)

Indenture, dated as of April 29, 2021, by and among Jazz Securities Designated Activity Company, the guarantors party thereto, U.S. Bank National Association, as trustee and U.S.... (Filed With SEC on April 29, 2021)

Jazz Pharmaceuticals Cash Bonus Plan (Ireland and Other Specified Affiliates) (Calendar Year 2021) (Filed With SEC on February 23, 2021)

Jazz Pharmaceuticals plc Cash Bonus Plan for U.S. Affiliates (approved October 30, 2020) (Filed With SEC on February 23, 2021)

Amended and Restated License Agreement, dated as of October 14, 2020, between Pharma Mar, S.A. and Jazz Pharmaceuticals Ireland Limited (Filed With SEC on February 23, 2021)

Master Manufacturing Services Agreement, dated as of October 1, 2015, by and between Jazz Pharmaceuticals Ireland Limited and Patheon Pharmaceuticals Inc (Filed With SEC on February 23, 2021)

Description of Share Capital (Filed With SEC on February 23, 2021)

Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals PLC (Filed With SEC on February 4, 2021)

Form of Non-U.S. Option Grant Notice and Non-U.S. Option Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007 Non-Employee Directors Stock Award Plan (Filed With SEC on November 2, 2020)

Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007... (Filed With SEC on November 2, 2020)

Amended and Restated Non-Employee Director Compensation Policy (approved (Filed With SEC on November 2, 2020)

Amended and Restated 2007 Non-Employee Directors Stock Award Plan (approved July 30, 2020) (Filed With SEC on August 4, 2020)

Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty Distribution Services, Inc (Filed With SEC on August 4, 2020)

Offer Letter, dated as of May 2, 2020, by and between Jazz Pharmaceuticals, Inc. and Kim Sablich (Filed With SEC on August 4, 2020)

Indenture, dated as of June 11, 2020 among Jazz Pharmaceuticals Public Limited Company, Jazz Investments I Limited and U.S. Bank National Association (Filed With SEC on June 11, 2020)

Amendment to Employment Contract, dated as of April 21, 2020, by and between Jazz Pharmaceuticals UK Limited and Samantha Pearce (Filed With SEC on May 5, 2020)

Amendment to Transition and Termination Agreement, dated as of March 31, 2020, by and between Jazz Pharmaceuticals, Inc. and Michael Miller (Filed With SEC on May 5, 2020)

Amendment to Employment Contract, dated as of February 26, 2020, by and between Jazz Pharmaceuticals Ireland Limited and Finbar Larkin (Filed With SEC on May 5, 2020)

Offer Letter, dated as of February 23, 2020, by and between Jazz Pharmaceuticals, Inc. and Rene Gal (Filed With SEC on May 5, 2020)

Contract Manufacturing Agreement, dated as of January 20, 2020, by and between Jazz Pharmaceuticals Ireland Limited and Siegfried AG (Filed With SEC on February 25, 2020)

Employment Contract, dated as of February 22, 2013, by and between Jazz Pharmaceuticals Ireland Limited and Finbar Larkin (Filed With SEC on February 25, 2020)

Description of Share Capital (Filed With SEC on February 25, 2020)

Compromise Agreement, dated as of October 5, 2019, by and between Jazz Pharmaceuticals Ireland Limited and Paul Treacy (Filed With SEC on February 25, 2020)

Jazz Pharmaceuticals Cash Bonus Plan (Ireland and Other Specified Affiliates) (Calendar Year 2020) (Filed With SEC on February 25, 2020)

Employment Contract, dated as of December 14, 2019, by and between Jazz Pharmaceuticals UK Limited and Samantha Pearce (Filed With SEC on February 25, 2020)

Equity Award Letter, dated as of December 9, 2019, by and between Jazz Pharmaceuticals UK Limited and Samantha Pearce (Filed With SEC on February 25, 2020)

Jazz Pharmaceuticals plc Cash Bonus Plan for U.S. Affiliates (approved October 30, 2019) (Filed With SEC on February 25, 2020)

License Agreement, dated as of December 19, 2019, between Pharma Mar, S.A. and Jazz Pharmaceuticals Ireland Limited (Filed With SEC on January 22, 2020)

Employment Agreement, dated as of May 16, 2012 by and between Patricia Carr and Jazz Pharmaceuticals plc (Filed With SEC on November 5, 2019)

Change in Control Stock Award Acceleration Agreement, dated as of May 15, 2016 by and between Jazz Pharmaceuticals plc and Patricia Carr (Filed With SEC on November 5, 2019)

Change in Control Severance Terms, dated as of May 15, 2016, by and between Jazz Pharmaceuticals Ireland Ltd. and Patricia Carr (Filed With SEC on November 5, 2019)

Transition and Termination Agreement, dated as of November 2, 2019, by and between Jazz Pharmaceuticals, Inc. and Mike Miller (Filed With SEC on November 5, 2019)

Offer Letter, dated as of July 5, 2019 by and between Jazz Pharmaceuticals, Inc. and Neena M. Patil (Filed With SEC on November 5, 2019)

Amended and Restated Executive Change in Control and Severance Benefit Plan, dated as of July 31, 2019 (Filed With SEC on November 5, 2019)

Letter Agreement, dated as of June 10, 2019, by and between Jazz Pharmaceuticals, Inc. and Suzanne Sawochka Hooper (Filed With SEC on August 6, 2019)

Offer Letter from Jazz Pharmaceuticals, Inc. to Robert Iannone dated as of April 11, 2019 (Filed With SEC on August 6, 2019)

Transition Employment Letter Agreement, dated as of February 6, 2019, by and between Jazz Pharmaceuticals, Inc. and Suzanne Sawochka Hooper (Filed With SEC on May 7, 2019)

Amendment No. 1 to Pharmacy Master Services Agreement, effective as of June 30, 2019, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty Distribution... (Filed With SEC on May 7, 2019)

Settlement Agreement, dated as of April 4, 2019, by and among United States of America, acting through the United States Department of Justice and on behalf of the Office of... (Filed With SEC on May 7, 2019)

Corporate Integrity Agreement, dated as of April 3, 2019, by and between Jazz Pharmaceuticals plc and the Office of Inspector General of the United States Department of Health and... (Filed With SEC on May 7, 2019)

Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc 2011 Equity Incentive Plan (Filed With SEC on May 7, 2019)

Form of Non-U.S. Option Grant Notice and Non-U.S. Option Agreement under the Jazz Pharmaceuticals plc 2011 Equity Incentive Plan (Filed With SEC on May 7, 2019)

Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007... (Filed With SEC on May 7, 2019)

Form of Non-U.S. Option Grant Notice and Non-U.S. Option Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007 Non-Employee Directors Stock Award Plan (Filed With SEC on May 7, 2019)

Jazz Pharmaceuticals plc Cash Bonus Plan for U.S. Affiliates (approved October 31, 2018) (Filed With SEC on February 26, 2019)

Jazz Pharmaceuticals Cash Bonus Plan (Ireland and Other Specified Affiliates) (Calendar Year 2019) (Filed With SEC on February 26, 2019)

Contract Variation Agreement by and between Porton Biopharma Limited and Jazz Pharmaceuticals France SAS, dated as of December 20, 2018 (Filed With SEC on February 26, 2019)

Jazz Pharmaceuticals plc (73)